{"date":"2025-05-20","count":40,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6734-2025-05-20-1951-s1l4g4","company_id":"6734","company":"安盛生","market":"興櫃","industry":"生技醫療","date":"2025-05-20","time":"19:51:31","subject":"公告本公司第三屆薪酬委員會委員任期屆滿","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安盛生（6734），2025-05-20 19:51，「公告本公司第三屆薪酬委員會委員任期屆滿」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6734-2025-05-20-1950-100yelq","company_id":"6734","company":"安盛生","market":"興櫃","industry":"生技醫療","date":"2025-05-20","time":"19:50:55","subject":"公告本公司第三屆審計委員會新任委員名單","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安盛生（6734），2025-05-20 19:50，「公告本公司第三屆審計委員會新任委員名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6734-2025-05-20-1950-18pbzus","company_id":"6734","company":"安盛生","market":"興櫃","industry":"生技醫療","date":"2025-05-20","time":"19:50:20","subject":"公告本公司114年股東常會通過解除新任董事競業禁止限制案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安盛生（6734），2025-05-20 19:50，「公告本公司114年股東常會通過解除新任董事競業禁止限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6461-2025-05-20-1811-mo7uyh","company_id":"6461","company":"益得","market":"上櫃","industry":"生技醫療","date":"2025-05-20","time":"18:11:36","subject":"公告本公司114年股東常會解除董事及其代表人競業禁止之限制","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益得（6461），2025-05-20 18:11，「公告本公司114年股東常會解除董事及其代表人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6461-2025-05-20-1811-ds864w","company_id":"6461","company":"益得","market":"上櫃","industry":"生技醫療","date":"2025-05-20","time":"18:11:17","subject":"公告本公司114年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益得（6461），2025-05-20 18:11，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6838-2025-05-20-1754-17d1872","company_id":"6838","company":"台新藥","market":"上市","industry":"生技醫療","date":"2025-05-20","time":"17:54:26","subject":"公告本公司向台灣食品藥物管理局申請眼部術後炎症和疼痛治療新藥APP13007上市查驗登記","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台新藥（6838），2025-05-20 17:54，「公告本公司向台灣食品藥物管理局申請眼部術後炎症和疼痛治療新藥APP13007上市查驗登記」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6734-2025-05-20-1748-qrsqda","company_id":"6734","company":"安盛生","market":"興櫃","industry":"生技醫療","date":"2025-05-20","time":"17:48:54","subject":"公告本公司獨立董事辭任","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安盛生（6734），2025-05-20 17:48，「公告本公司獨立董事辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6734-2025-05-20-1748-bww4av","company_id":"6734","company":"安盛生","market":"興櫃","industry":"生技醫療","date":"2025-05-20","time":"17:48:05","subject":"公告本公司114年股東常會全面改選董事(含獨立董事)當選名單","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安盛生（6734），2025-05-20 17:48，「公告本公司114年股東常會全面改選董事(含獨立董事)當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6734-2025-05-20-1747-ds864w","company_id":"6734","company":"安盛生","market":"興櫃","industry":"生技醫療","date":"2025-05-20","time":"17:47:24","subject":"公告本公司114年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安盛生（6734），2025-05-20 17:47，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6861-2025-05-20-1739-v1gwxu","company_id":"6861","company":"睿生光電","market":"上市","industry":"生技醫療","date":"2025-05-20","time":"17:39:52","subject":"公告本公司調整現金股利配息率","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：睿生光電（6861），2025-05-20 17:39，「公告本公司調整現金股利配息率」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-5312-2025-05-20-1700-7nyl1g","company_id":"5312","company":"寶島科","market":"上櫃","industry":"生技醫療","date":"2025-05-20","time":"17:00:11","subject":"代重要子公司寶崴光學(股)公司公告股利分派事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：寶島科（5312），2025-05-20 17:00，「代重要子公司寶崴光學(股)公司公告股利分派事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6569-2025-05-20-1624-1nwqzhz","company_id":"6569","company":"醫揚","market":"上櫃","industry":"生技醫療","date":"2025-05-20","time":"16:24:50","subject":"本公司股東常會決議通過解除新任董事及其代表人競業行為之限制案","clause":"第21款","fact_date":"2025-05-20","cite_as":"公開資訊觀測站重大訊息：醫揚（6569），2025-05-20 16:24，「本公司股東常會決議通過解除新任董事及其代表人競業行為之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6569-2025-05-20-1624-cwb10f","company_id":"6569","company":"醫揚","market":"上櫃","industry":"生技醫療","date":"2025-05-20","time":"16:24:24","subject":"公告本公司第二屆風險管理委員會委員","clause":"第6款","fact_date":"2025-05-20","cite_as":"公開資訊觀測站重大訊息：醫揚（6569），2025-05-20 16:24，「公告本公司第二屆風險管理委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6569-2025-05-20-1623-1nwix1l","company_id":"6569","company":"醫揚","market":"上櫃","industry":"生技醫療","date":"2025-05-20","time":"16:23:51","subject":"公告本公司第二屆永續發展委員會委員","clause":"第6款","fact_date":"2025-05-20","cite_as":"公開資訊觀測站重大訊息：醫揚（6569），2025-05-20 16:23，「公告本公司第二屆永續發展委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6569-2025-05-20-1623-1tes7vq","company_id":"6569","company":"醫揚","market":"上櫃","industry":"生技醫療","date":"2025-05-20","time":"16:23:21","subject":"公告本公司第五屆薪資報酬委員會委員","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：醫揚（6569），2025-05-20 16:23，「公告本公司第五屆薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6569-2025-05-20-1622-1joci1s","company_id":"6569","company":"醫揚","market":"上櫃","industry":"生技醫療","date":"2025-05-20","time":"16:22:58","subject":"公告本公司第六屆審計委員會成員","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：醫揚（6569），2025-05-20 16:22，「公告本公司第六屆審計委員會成員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6569-2025-05-20-1622-ds864w","company_id":"6569","company":"醫揚","market":"上櫃","industry":"生技醫療","date":"2025-05-20","time":"16:22:38","subject":"公告本公司114年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：醫揚（6569），2025-05-20 16:22，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6569-2025-05-20-1622-19m2jjq","company_id":"6569","company":"醫揚","market":"上櫃","industry":"生技醫療","date":"2025-05-20","time":"16:22:18","subject":"公告本公司114年股東常會全面改選董事事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：醫揚（6569），2025-05-20 16:22，「公告本公司114年股東常會全面改選董事事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6569-2025-05-20-1621-1dbnt5w","company_id":"6569","company":"醫揚","market":"上櫃","industry":"生技醫療","date":"2025-05-20","time":"16:21:24","subject":"公告本公司董事改選完成，推舉董事長","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：醫揚（6569），2025-05-20 16:21，「公告本公司董事改選完成，推舉董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6534-2025-05-20-1612-hiebb2","company_id":"6534","company":"正瀚-創","market":"上市","industry":"生技醫療","date":"2025-05-20","time":"16:12:36","subject":"公告本公司114年股東會重要決議事項","clause":"第18款","fact_date":"2025-05-20","cite_as":"公開資訊觀測站重大訊息：正瀚-創（6534），2025-05-20 16:12，「公告本公司114年股東會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6534-2025-05-20-1610-54swv6","company_id":"6534","company":"正瀚-創","market":"上市","industry":"生技醫療","date":"2025-05-20","time":"16:10:12","subject":"公告本公司法人董事改派代表人","clause":"第6款","fact_date":"2025-05-20","cite_as":"公開資訊觀測站重大訊息：正瀚-創（6534），2025-05-20 16:10，「公告本公司法人董事改派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8432-2025-05-20-1549-11a2puo","company_id":"8432","company":"東生華","market":"上櫃","industry":"生技醫療","date":"2025-05-20","time":"15:49:08","subject":"代重要子公司創益生技股份有限公司公告股東會決議通過解除董事競業禁止之限制","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：東生華（8432），2025-05-20 15:49，「代重要子公司創益生技股份有限公司公告股東會決議通過解除董事競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8432-2025-05-20-1548-1oiv3tk","company_id":"8432","company":"東生華","market":"上櫃","industry":"生技醫療","date":"2025-05-20","time":"15:48:43","subject":"代重要子公司創益生技股份有限公司公告114年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：東生華（8432），2025-05-20 15:48，「代重要子公司創益生技股份有限公司公告114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6918-2025-05-20-1536-14opyqv","company_id":"6918","company":"愛派司","market":"上市","industry":"生技醫療","date":"2025-05-20","time":"15:36:50","subject":"公告本公司股票初次上市前現金增資發行新股事宜（暫定承銷價格及相關時程）","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：愛派司（6918），2025-05-20 15:36，「公告本公司股票初次上市前現金增資發行新股事宜（暫定承銷價格及相關時程）」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6918-2025-05-20-1534-1xtvx4b","company_id":"6918","company":"愛派司","market":"上市","industry":"生技醫療","date":"2025-05-20","time":"15:34:38","subject":"公告本公司初次上市現金增資股款委託代收及存儲價款機構","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：愛派司（6918），2025-05-20 15:34，「公告本公司初次上市現金增資股款委託代收及存儲價款機構」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6918-2025-05-20-1532-qkrt5g","company_id":"6918","company":"愛派司","market":"上市","industry":"生技醫療","date":"2025-05-20","time":"15:32:43","subject":"公告本公司股務代理機構名稱、辦公處所及聯絡電話","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：愛派司（6918），2025-05-20 15:32，「公告本公司股務代理機構名稱、辦公處所及聯絡電話」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2025-05-20-1528-7gcg8","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2025-05-20","time":"15:28:43","subject":"公告本公司114年5月20日股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2025-05-20 15:28，「公告本公司114年5月20日股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6794-2025-05-20-1445-ds864w","company_id":"6794","company":"向榮生技","market":"上市","industry":"生技醫療","date":"2025-05-20","time":"14:45:02","subject":"公告本公司114年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：向榮生技（6794），2025-05-20 14:45，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3218-2025-05-20-1434-3ht9e4","company_id":"3218","company":"大學光","market":"上櫃","industry":"生技醫療","date":"2025-05-20","time":"14:34:51","subject":"本公司受邀參加花旗環球證券之2025台灣科技論壇","clause":"第12款","fact_date":"2025-05-21","cite_as":"公開資訊觀測站重大訊息：大學光（3218），2025-05-20 14:34，「本公司受邀參加花旗環球證券之2025台灣科技論壇」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7724-2025-05-20-1433-1eehtoh","company_id":"7724","company":"諾亞克","market":"興櫃","industry":"生技醫療","date":"2025-05-20","time":"14:33:27","subject":"諾亞克(7724)營業地址變更案","clause":"第44款","fact_date":"2025-05-20","cite_as":"公開資訊觀測站重大訊息：諾亞克（7724），2025-05-20 14:33，「諾亞克(7724)營業地址變更案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-05-20-1432-1puubym","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-05-20","time":"14:32:41","subject":"代重要子公司鼎晉生技股份有限公司公告114年股東常會決議解除董事競業禁止之限制","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-05-20 14:32，「代重要子公司鼎晉生技股份有限公司公告114年股東常會決議解除董事競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6712-2025-05-20-1432-baw3vv","company_id":"6712","company":"長聖","market":"上櫃","industry":"生技醫療","date":"2025-05-20","time":"14:32:25","subject":"更正本公司114年1~4月當月及累計營收公告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長聖（6712），2025-05-20 14:32，「更正本公司114年1~4月當月及累計營收公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-05-20-1431-9ybi6b","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-05-20","time":"14:31:04","subject":"代重要子公司鼎晉生技股份有限公司公告114年股東常會重要決議事項及累積虧損達實收資本額二分之一","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-05-20 14:31，「代重要子公司鼎晉生技股份有限公司公告114年股東常會重要決議事項及累積虧損達實收資本額二分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6847-2025-05-20-1424-1gwejfe","company_id":"6847","company":"普瑞博","market":"興櫃","industry":"生技醫療","date":"2025-05-20","time":"14:24:14","subject":"(補充113/8/13公告)公告本公司董事會決議與台塑生醫合資技術入股事宜","clause":"第8款","fact_date":"2025-05-20","cite_as":"公開資訊觀測站重大訊息：普瑞博（6847），2025-05-20 14:24，「(補充113/8/13公告)公告本公司董事會決議與台塑生醫合資技術入股事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6847-2025-05-20-1423-ds864w","company_id":"6847","company":"普瑞博","market":"興櫃","industry":"生技醫療","date":"2025-05-20","time":"14:23:21","subject":"公告本公司114年股東常會重要決議事項","clause":"第15款","fact_date":"2025-05-20","cite_as":"公開資訊觀測站重大訊息：普瑞博（6847），2025-05-20 14:23，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6847-2025-05-20-1422-1yu0dhh","company_id":"6847","company":"普瑞博","market":"興櫃","industry":"生技醫療","date":"2025-05-20","time":"14:22:24","subject":"本公司董事會通過公司稽核主管任命案","clause":"第11款","fact_date":"2025-05-20","cite_as":"公開資訊觀測站重大訊息：普瑞博（6847），2025-05-20 14:22，「本公司董事會通過公司稽核主管任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1813-2025-05-20-1419-na4vgy","company_id":"1813","company":"寶利徠","market":"上櫃","industry":"生技醫療","date":"2025-05-20","time":"14:19:03","subject":"公告本公司股東常會重要決議事項","clause":"第18款","fact_date":"2025-05-20","cite_as":"公開資訊觀測站重大訊息：寶利徠（1813），2025-05-20 14:19，「公告本公司股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6242-2025-05-20-1417-ds864w","company_id":"6242","company":"立康","market":"上櫃","industry":"生技醫療","date":"2025-05-20","time":"14:17:08","subject":"公告本公司114年股東常會重要決議事項","clause":"第18款","fact_date":"2025-05-20","cite_as":"公開資訊觀測站重大訊息：立康（6242），2025-05-20 14:17，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6861-2025-05-20-1334-1o6asl9","company_id":"6861","company":"睿生光電","market":"上市","industry":"生技醫療","date":"2025-05-20","time":"13:34:16","subject":"公告本公司訂定民國114年發放現金股利基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：睿生光電（6861），2025-05-20 13:34，「公告本公司訂定民國114年發放現金股利基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6861-2025-05-20-1334-t6rqxo","company_id":"6861","company":"睿生光電","market":"上市","industry":"生技醫療","date":"2025-05-20","time":"13:34:00","subject":"公告本公司114年股東常會重要決議","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：睿生光電（6861），2025-05-20 13:34，「公告本公司114年股東常會重要決議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}